Translational research

The National Center PreciDIAB‘s mission is to develop 21st century medicine through the 4P approach – predictive, preventive, personalized and participatory – perfectly suited to diabetes and obesity.

The objective of PreciDIAB’s translational research projects is to answer the questions raised by clinicians who work closely with patients, in particular within the various clinical studies of PreciDIAB.

Our researchers use their expertise in the multi-omics field – (epi) genomics, metabolomics and microbiotic signatures – to identify the biomarkers that will make it possible to identify and treat people likely to develop diabetes and its complications in order to offer them the treatment best suited to their condition. This research is made possible by the use of state-of-the-art platforms and equipment.